Study guide

4.1 Laboratory Procedures

CMA Certified Medical Assistant Exam Exam

Track your progress as you read

Finished sections get a check mark.

1 Introduction: CMA (AAMA) Exam Overview

CMA (AAMA) Certification Exam Overview CMA Certification Process & Eligibility Study Strategies & Test-Taking Tips

2 Chapter 1: General Knowledge (21%)

1.1 Anatomy, Physiology & Medical Terminology 1.2 Pharmacology & Nutrition 1.3 Psychology, Human Behavior & Lifespan Development 1.4 Immunizations, CDC Schedules & Vaccine Safety

3 Chapter 1B: Safety, Infection Control & Emergency Preparedness

Safety, Infection Control & Medical Asepsis Emergency Management, First Aid & Office Preparedness

4 Chapter 2: Administrative Knowledge (20%)

2.1 Medical Business Practices & Insurance 2.2 Scheduling & Records Management

5 Chapter 3: Clinical Knowledge — Patient Care

3.1 Vital Signs & Patient Assessment 3.2 Clinical Procedures & Specimen Collection

6 Chapter 4: Clinical Knowledge — Diagnostic & Lab

4.1 Laboratory Procedures 4.2 Diagnostic Testing

7 Chapter 5: Professional Practice & Communication

5.1 Professional Communication & Patient Education 5.2 Legal & Ethical Practice

4.1 Laboratory Procedures

Key Takeaways Explain This Topic AI

CLIA (Clinical Laboratory Improvement Amendments) classifies lab tests into three categories: waived, moderate complexity, and high complexity

CLIA-waived tests can be performed by medical assistants with minimal training — examples include rapid strep, urine dipstick, blood glucose, and urine pregnancy tests

Quality control (QC) must be performed on all lab equipment according to manufacturer instructions and documented in a QC log

A complete blood count (CBC) measures red blood cells (RBCs), white blood cells (WBCs), hemoglobin, hematocrit, and platelets

Normal adult WBC count is 4,500-11,000/mcL; elevated WBC (leukocytosis) suggests infection; decreased WBC (leukopenia) suggests immunosuppression

Urinalysis includes physical examination (color, clarity, specific gravity), chemical analysis (dipstick), and microscopic examination

Normal fasting blood glucose is 70-100 mg/dL; diabetes is diagnosed at fasting glucose of 126 mg/dL or higher on two occasions

Hemoglobin A1C reflects average blood glucose over the past 2-3 months — normal is below 5.7%, prediabetes is 5.7-6.4%, and diabetes is 6.5% or higher

Last updated: February 2026

Medical assistants perform a variety of laboratory procedures in the clinical setting. Understanding CLIA regulations, quality control, normal lab values, and proper specimen handling is essential for safe and accurate laboratory testing.

CLIA (Clinical Laboratory Improvement Amendments)

CLIA was enacted in 1988 to ensure quality laboratory testing. It classifies tests into three categories:

Category Complexity Who Can Perform Examples

Waived Minimal complexity, low risk of error Medical assistants, trained office staff Rapid strep, urine dipstick, blood glucose, pregnancy test, hemoglobin, INR (point-of-care)

Moderate complexity Requires more training and skill Lab technicians, trained personnel CBC (automated), urinalysis (microscopic), Gram stain

High complexity Requires advanced training and expertise Medical technologists, pathologists Cytology, histopathology, flow cytometry

  • CLIA Requirements for Medical Offices
  • Must have a CLIA certificate appropriate for the testing complexity level performed
  • Certificate of Waiver (CoW) allows only waived tests — most common for physician offices
  • Must follow manufacturer's instructions for all testing procedures
  • Must perform and document quality control (QC) as specified
  • Records must be maintained for at least 2 years
  • Quality Control (QC)

Quality control ensures laboratory test results are accurate and reliable:

  • QC Component Description
  • Control samples Known-value samples run alongside patient samples to verify accuracy
  • Calibration Adjusting instruments to ensure accurate readings
  • Proficiency testing External evaluation by a reference lab to verify accuracy
  • QC log Written record of all QC results, dates, and corrective actions
  • Levey-Jennings chart Graph tracking QC results over time to identify trends or shifts
  • Key QC Rules
  • Run controls at the beginning of each day testing is performed (or per manufacturer instructions)
  • Controls must fall within the acceptable range before patient samples can be run
  • If controls are out of range : Do NOT run patient samples — troubleshoot, repeat controls, document
  • Document all QC results , including out-of-range values and corrective actions taken
  • Reagent management : Check expiration dates, store properly, do not use expired reagents
  • Hematology
  • Complete Blood Count (CBC)

The CBC is one of the most commonly ordered blood tests:

  • Component Normal Adult Range Clinical Significance
  • RBC (Red Blood Cells) M: 4.5-5.5 million/mcL; F: 4.0-5.0 million/mcL Low = anemia; High = polycythemia
  • WBC (White Blood Cells) 4,500-11,000/mcL High (leukocytosis) = infection; Low (leukopenia) = immunosuppression
  • Hemoglobin (Hgb) M: 13.5-17.5 g/dL; F: 12.0-16.0 g/dL Oxygen-carrying capacity; low = anemia
  • Hematocrit (Hct) M: 38-50%; F: 36-44% Percentage of blood volume that is RBCs
  • Platelets 150,000-400,000/mcL Low (thrombocytopenia) = bleeding risk; High (thrombocytosis) = clotting risk
  • MCV 80-100 fL Size of RBCs: low = microcytic; high = macrocytic
  • WBC Differential

The WBC differential breaks down the types of white blood cells:

  • WBC Type Normal % Function
  • Neutrophils 55-70% Fight bacterial infections (most abundant)
  • Lymphocytes 20-40% Immune response (T cells, B cells); increased in viral infections
  • Monocytes 2-8% Phagocytosis (engulf pathogens and debris)
  • Eosinophils 1-4% Fight parasites; increased in allergic reactions
  • Basophils 0.5-1% Release histamine and heparin; involved in allergic responses

Memory aid: " N ever L et M onkeys E at B ananas" (Neutrophils, Lymphocytes, Monocytes, Eosinophils, Basophils — in order from most to least abundant)

Urinalysis

A complete urinalysis has three components:

1. Physical Examination

  • Parameter Normal Abnormal Findings
  • Color Pale yellow to amber Red/brown (blood), dark amber (dehydration), orange (bilirubin), cloudy (infection)
  • Clarity Clear to slightly hazy Turbid/cloudy (infection, crystals, mucus)

Specific gravity 1.005-1.030 High = concentrated (dehydration); Low = dilute (overhydration, diabetes insipidus)

2. Chemical Analysis (Dipstick)

  • Reagent Pad Normal Clinical Significance of Abnormal
  • pH 4.5-8.0 (avg 6.0) Acidic: high-protein diet, DKA; Alkaline: UTI, vegetarian diet
  • Protein Negative Positive: kidney disease, preeclampsia, UTI
  • Glucose Negative Positive: diabetes mellitus (renal threshold ~180 mg/dL)
  • Ketones Negative Positive: DKA, starvation, low-carb diets
  • Blood Negative Positive: infection, stones, trauma, menstrual contamination
  • Bilirubin Negative Positive: liver disease, bile duct obstruction
  • Leukocyte esterase Negative Positive: UTI (presence of WBCs)
  • Nitrite Negative Positive: UTI (bacteria convert nitrate to nitrite)
  • 3. Microscopic Examination (Moderate Complexity)
  • Finding Significance
  • RBCs Bleeding, trauma, stones, infection
  • WBCs Infection (>5 per HPF is abnormal)
  • Bacteria Urinary tract infection
  • Casts Kidney disease (specific type indicates cause)
  • Crystals Kidney stones, metabolic disorders
  • Epithelial cells Contamination (large numbers) or kidney disease
  • Blood Chemistry
  • Common Blood Chemistry Values
  • Test Normal Range Clinical Use
  • Fasting blood glucose 70-100 mg/dL Diabetes screening (>126 = diabetes)
  • Hemoglobin A1C <5.7% 2-3 month glucose average (>6.5% = diabetes)
  • BUN (Blood Urea Nitrogen) 7-20 mg/dL Kidney function
  • Creatinine 0.7-1.3 mg/dL Kidney function (more specific than BUN)
  • Total cholesterol <200 mg/dL Heart disease risk
  • LDL ("bad") <100 mg/dL Heart disease risk — lower is better
  • HDL ("good") >40 mg/dL (M), >50 mg/dL (F) Heart disease protection — higher is better
  • Triglycerides <150 mg/dL Heart disease risk
  • TSH 0.4-4.0 mIU/L Thyroid function (high = hypothyroid; low = hyperthyroid)
  • Specimen Handling
  • Key Rules
  • Label at the time of collection — never pre-label specimens
  • Include: patient name, DOB, date/time of collection, collector initials, test requested
  • Transport specimens to the lab promptly — most within 30-60 minutes
  • Specimens requiring refrigeration: urine for culture (if delayed), some blood chemistries
  • Never leave specimens in extreme temperatures (heat or direct sunlight)
  • Maintain chain of custody for drug testing and forensic specimens
  • Microbiology Basics
  • Types of Microorganisms

Type Characteristics Examples Treatment

Bacteria Single-celled prokaryotes; classified by shape and Gram stain Staphylococcus, Streptococcus, E. coli Antibiotics

Viruses Non-living, require host cell to replicate Influenza, HIV, COVID-19, hepatitis Antivirals (limited), vaccines

  • Fungi Eukaryotic; includes yeasts and molds Candida (yeast), Tinea (ringworm) Antifungals
  • Parasites Organisms living in/on a host Giardia, pinworm, malaria Antiparasitics
  • Protozoa Single-celled eukaryotes Amoeba, Giardia, Plasmodium Antiprotozoals
  • Bacterial Classifications
  • Classification Shape Examples
  • Cocci Spherical/round Staphylococcus, Streptococcus
  • Bacilli Rod-shaped E. coli, Clostridium
  • Spirilla Spiral-shaped Treponema (syphilis), Borrelia (Lyme)
  • Gram Stain
  • Gram-positive : Stain purple/blue; thick cell wall (e.g., Staphylococcus, Streptococcus)
  • Gram-negative : Stain pink/red; thin cell wall with outer membrane (e.g., E. coli, Neisseria)
  • Gram stain helps guide antibiotic selection before culture results are available
  • Specimen Collection for Cultures
  • Use sterile technique to avoid contamination
  • Throat culture : Swab posterior pharynx and tonsils (not tongue or cheeks); used for Group A Strep
  • Wound culture : Collect from the wound margin (not surface discharge)
  • Urine culture : Clean-catch midstream specimen to reduce contamination
  • Blood culture : Collected in special blood culture bottles (yellow-top tubes); drawn from two separate sites
  • Label all specimens immediately with patient name, DOB, date/time, source, and collector initials
  • Transport to lab promptly — delayed transport may allow overgrowth of contaminants
  • Coagulation Studies
  • Test Normal Range Purpose
  • PT (Prothrombin Time) 11-13.5 seconds Monitors warfarin (Coumadin) therapy; evaluates extrinsic pathway

INR (International Normalized Ratio) 0.8-1.1 (normal); 2.0-3.0 (therapeutic on warfarin) Standardized PT measurement for warfarin monitoring

  • PTT (Partial Thromboplastin Time) 25-35 seconds Monitors heparin therapy; evaluates intrinsic pathway
  • aPTT (Activated PTT) 30-40 seconds More sensitive version of PTT
  • Bleeding time 2-7 minutes Evaluates platelet function
  • Key Coagulation Facts
  • Warfarin is monitored with PT/INR (extrinsic pathway)
  • Heparin is monitored with PTT/aPTT (intrinsic pathway)
  • Elevated PT/INR = increased bleeding risk; may need to reduce warfarin dose

Light blue top tubes (sodium citrate) are used for coagulation studies and must be filled to the exact line — underfilling causes inaccurate results

Normal WBC Differential (Approximate Percentages)